Back to search

France· FR:61448776

COROTROPE 10 mg/10 ml, solution injectable IV

A milrinone product containing milrinone, registered in France by SANOFI WINTHROP INDUSTRIE. The same ATC class is registered in 16 of our 19 countries.

ATC C01CE02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCOROTROPE 10 mg/10 ml, solution injec…ATCC01CE02REGISTER NO.FR:61448776PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Milrinone is registered in 16 of 19 countries.

Countries holding a registration under ATC C01CE02 (milrinone), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 8 of them publish a price we can compare per daily dose

Milrinone · ATC C01CE02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
MILRINONE
Manufacturer
SANOFI WINTHROP INDUSTRIE
Country
France (FR)
ATC code
C01CE02
ATC class
Milrinone
Defined daily dose
50 mg, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955602293
    10 ampoule(s) en verre de 10 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for milrinone.

Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Milrinone · interactions on record

5 records

  • 5 moderate

Most severe, free to view

  • ProcarbazineL01XB01moderate
  • AnagrelideL01XX35moderate
  • OzanimodL04AA38moderate
  • OzanimodL04AE02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Milrinone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All milrinone products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Asicor, Milrinon Carino
  • Belgium · Corotrope
  • Bulgaria · Milrinon Makpharm
  • Czechia · Asicord, Corotrop
  • Germany · Corotrop, Milrinon Carinopharm
  • Denmark · Milnocor, Milrinon Stragen
  • Spain · Corotrope, Milrinone
  • Finland · Milnocor, Milrinon Stragen
  • United Kingdom (Northern Ireland) · Milrinone Carinopharm, Milrinone Macure Pharma Uk
  • Greece · Corotrope
  • Croatia · Milrinon Makpharm
  • Hungary · Corotrope, Unacor
  • Ireland · Milrinone Pinewood Laboratories
  • Luxembourg · Corotrope
  • Malta · Milrinone Tillomed
  • Netherlands · Milrinon Carinopharm, Milrinon Devrimed
  • Norway · Milnocor, Milrinon Stragen
  • Poland · Asicor, Corotrope
  • Portugal · Corotrope
  • Romania · Milrinone Zentiva, Unacor
  • Sweden · Corotrop, Milrinon Carinopharm
  • Slovenia · Milrinon Makpharm
  • Slovakia · Asicord, Corotrope Inj

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/19e5555b-cce3-4951-9e3f-0e2d0115e912
GET /v1/drugs/19e5555b-cce3-4951-9e3f-0e2d0115e912?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61448776",
  "date_amm": "1987-10-16",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "MILRINONE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about milrinone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.